tiprankstipranks
Trending News
More News >
Medical Facilities Corporation (TSE:DR)
TSX:DR
Canadian Market

Medical Facilities (DR) Ratios

Compare
75 Followers

Medical Facilities Ratios

TSE:DR's free cash flow for Q4 2024 was $0.17. For the 2024 fiscal year, TSE:DR's free cash flow was decreased by $ and operating cash flow was $0.17. See a summary of the company’s cash flow.
Ratios
TTM
Dec 24Dec 23Dec 22Dec 21
Liquidity Ratios
Current Ratio
1.86 1.24 1.37 1.83 1.44
Quick Ratio
1.79 1.13 1.27 1.70 1.35
Cash Ratio
1.22 0.29 0.40 0.75 0.65
Solvency Ratio
0.47 0.17 0.13 0.27 0.23
Operating Cash Flow Ratio
0.94 0.88 0.66 0.93 0.86
Short-Term Operating Cash Flow Coverage
8.02 5.07 5.86 14.29 4.59
Net Current Asset Value
$ -33.51M$ -133.82M$ -143.77M$ -118.39M$ -135.23M
Leverage Ratios
Debt-to-Assets Ratio
0.21 0.33 0.38 0.32 0.35
Debt-to-Equity Ratio
0.61 1.36 1.81 1.05 1.27
Debt-to-Capital Ratio
0.38 0.58 0.64 0.51 0.56
Long-Term Debt-to-Capital Ratio
0.16 0.39 0.49 0.36 0.38
Financial Leverage Ratio
2.84 4.13 4.77 3.33 3.58
Debt Service Coverage Ratio
3.93 2.66 2.76 3.19 2.75
Interest Coverage Ratio
5.10 4.07 3.64 3.01 4.72
Debt to Market Cap
0.00 0.40 0.49 0.35 0.57
Interest Debt Per Share
0.00 5.28 5.31 5.36 5.67
Net Debt to EBITDA
-0.42 1.03 1.60 0.77 1.00
Profitability Margins
Gross Profit Margin
66.32%66.58%66.10%67.38%66.77%
EBIT Margin
19.06%15.45%7.16%19.22%18.73%
EBITDA Margin
24.91%20.28%15.95%25.94%26.40%
Operating Profit Margin
18.59%15.06%11.06%19.41%18.63%
Pretax Profit Margin
15.42%11.74%4.12%12.77%11.48%
Net Profit Margin
22.17%4.15%2.90%11.66%10.28%
Continuous Operations Profit Margin
17.13%9.87%2.90%11.66%10.28%
Net Income Per EBT
143.79%35.36%70.25%91.36%89.57%
EBT Per EBIT
82.92%77.97%37.29%65.78%61.63%
Return on Assets (ROA)
21.22%5.21%3.25%10.40%8.19%
Return on Equity (ROE)
60.23%21.52%15.54%34.67%29.34%
Return on Capital Employed (ROCE)
23.95%24.68%16.13%21.16%19.08%
Return on Invested Capital (ROIC)
24.76%19.10%10.61%18.58%15.84%
Return on Tangible Assets
29.58%8.30%5.04%15.68%12.50%
Earnings Yield
-10.82%7.06%20.23%21.77%
Efficiency Ratios
Receivables Turnover
6.50 7.21 6.63 5.91 5.66
Payables Turnover
6.59 6.43 5.45 5.43 4.94
Inventory Turnover
19.23 16.53 15.60 12.21 12.96
Fixed Asset Turnover
3.99 3.71 3.40 3.00 2.64
Asset Turnover
0.96 1.26 1.12 0.89 0.80
Working Capital Turnover Ratio
6.89 17.04 8.50 7.09 6.24
Cash Conversion Cycle
19.78 15.92 11.50 24.45 18.75
Days of Sales Outstanding
56.19 50.60 55.06 61.76 64.44
Days of Inventory Outstanding
18.98 22.08 23.40 29.89 28.16
Days of Payables Outstanding
55.38 56.75 66.96 67.20 73.85
Operating Cycle
75.16 72.68 78.46 91.65 92.60
Cash Flow Ratios
Operating Cash Flow Per Share
0.00 2.88 1.94 2.43 2.80
Free Cash Flow Per Share
0.00 2.24 1.71 2.16 2.56
CapEx Per Share
0.00 0.64 0.23 0.27 0.24
Free Cash Flow to Operating Cash Flow
0.92 0.78 0.88 0.89 0.91
Dividend Paid and CapEx Coverage Ratio
6.32 3.29 4.01 4.93 6.49
Capital Expenditure Coverage Ratio
11.78 4.53 8.49 8.98 11.58
Operating Cash Flow Coverage Ratio
1.13 0.62 0.40 0.54 0.54
Operating Cash Flow to Sales Ratio
0.25 0.16 0.13 0.19 0.24
Free Cash Flow Yield
0.00%33.14%28.88%29.25%46.30%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
0.00 9.24 14.17 4.94 4.59
Price-to-Sales (P/S) Ratio
0.00 0.38 0.41 0.58 0.47
Price-to-Book (P/B) Ratio
0.00 1.99 2.20 1.71 1.35
Price-to-Free Cash Flow (P/FCF) Ratio
0.00 3.02 3.46 3.42 2.16
Price-to-Operating Cash Flow Ratio
0.00 2.35 3.06 3.04 1.97
Price-to-Earnings Growth (PEG) Ratio
0.00 0.13 -0.20 0.20 -0.12
Price-to-Fair Value
0.00 1.99 2.20 1.71 1.35
Enterprise Value Multiple
-0.42 2.92 4.17 3.00 2.79
EV to EBITDA
-0.42 2.92 4.17 3.00 2.79
EV to Sales
-0.10 0.59 0.66 0.78 0.74
EV to Free Cash Flow
-0.45 4.65 5.61 4.61 3.36
EV to Operating Cash Flow
-0.41 3.63 4.95 4.09 3.07
Tangible Book Value Per Share
0.00 -0.54 -0.65 0.94 0.56
Shareholders’ Equity Per Share
0.00 3.40 2.69 4.31 4.10
Tax and Other Ratios
Effective Tax Rate
-0.11 0.16 0.30 0.09 0.10
Revenue Per Share
0.00 17.64 14.46 12.82 11.70
Net Income Per Share
0.00 0.73 0.42 1.50 1.20
Tax Burden
1.44 0.35 0.70 0.91 0.90
Interest Burden
0.81 0.76 0.58 0.66 0.61
Research & Development to Revenue
0.00 0.00 0.00 0.00 0.00
SG&A to Revenue
0.46 0.47 0.47 0.45 0.48
Stock-Based Compensation to Revenue
>-0.01 >-0.01 >-0.01 <0.01 <0.01
Income Quality
0.79 1.65 4.64 1.63 2.44
Currency in USD
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis